The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.
Publication
, Journal Article
Goldstein, LB; Suarez, JI
Published in: Neurology
December 15, 2009
Duke Scholars
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
December 15, 2009
Volume
73
Issue
24
Start / End Page
2058 / 2059
Location
United States
Related Subject Headings
- Stroke
- Preoperative Care
- Neurology & Neurosurgery
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Enzyme Inhibitors
- Cytoprotection
- Coronary Artery Bypass
- Brain Ischemia
- 3209 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B., & Suarez, J. I. (2009). The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology, 73(24), 2058–2059. https://doi.org/10.1212/WNL.0b013e3181c6785c
Goldstein, Larry B., and Jose I. Suarez. “The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.” Neurology 73, no. 24 (December 15, 2009): 2058–59. https://doi.org/10.1212/WNL.0b013e3181c6785c.
Goldstein LB, Suarez JI. The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009 Dec 15;73(24):2058–9.
Goldstein, Larry B., and Jose I. Suarez. “The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer.” Neurology, vol. 73, no. 24, Dec. 2009, pp. 2058–59. Pubmed, doi:10.1212/WNL.0b013e3181c6785c.
Goldstein LB, Suarez JI. The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. Neurology. 2009 Dec 15;73(24):2058–2059.
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
December 15, 2009
Volume
73
Issue
24
Start / End Page
2058 / 2059
Location
United States
Related Subject Headings
- Stroke
- Preoperative Care
- Neurology & Neurosurgery
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Enzyme Inhibitors
- Cytoprotection
- Coronary Artery Bypass
- Brain Ischemia
- 3209 Neurosciences